AMRI Financial Facts
Selling, general and administrative: 37.3MRecurring royalties: 1.06M
See Full Income Statement
Cash and cash equivalents: 44.76M
Pension and postretirement benefits: 19.85M
See Full Balance Sheet
Albany Molecular Research Inc. (AMRI) Earnings
|
Expand Research on AMRI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +5.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/9/17 |  |
Q117 | $0.13 | $0.12 | +$0.01 | $163.8M | $161.45M | = |  | | Details |
| 2/21/17 | |
Q416 | $0.34 | $0.48 | -$0.14 | $191.3M | $221.3M |  |
| | Details |
11/8/16  |
|
Q316 | $0.17 | $0.13 | +$0.04 | $151.7M | $160.75M | = | | | Details |
| 8/4/16 |
|
Q216 | $0.36 | $0.32 | +$0.04 | $116.5M | $123.1M | = | | | Details |
| 5/10/16 | Q116 | $0.07 | $0.21 | -$0.14 | $102.8M | $107.2M | = | | | Details | |
| 2/17/16 |
|
Q415 | $0.40 | $0.36 | +$0.04 | $126.4M | $133.4M | = | | | Details |
| 11/5/15 |
|
Q315 | $0.14 | $0.13 | +$0.01 | $101.4M | $95.15M | = | | | Details |
| 8/4/15 |
|
Q215 | $0.22 | $0.18 | +$0.04 | $85.2M | $85M | = | | | Details |
